80 results
8-K
EX-99.1
FGEN
FibroGen Inc
26 Feb 24
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
myelodysplastic syndromes at American Society of Hematology Annual Meeting.
Corporate
Thane Wettig appointed Chief Executive Officer.
Successful execution
8-K
EX-99.1
97c78f5vzulm1wc5tz
6 Nov 23
FibroGen Reports Third Quarter 2023 Financial Results
4:05pm
CORRESP
cmu 5ybv6dmq03soh3
16 Dec 21
Correspondence with SEC
12:00am
8-K
EX-99.1
05whb7xoii3x481 im
9 Nov 21
FibroGen Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
ft0kdcy4pcb7f8ld58
9 Aug 21
FibroGen Reports Second Quarter 2021 Financial Results
4:05pm